# Auro Peptides Limited – FDA 483, Aug 21, 2026

Source: https://www.keypedia.com/records/483/auro-peptides-limited/a073b5c5-a06f-4cfb-b180-d57453fe6059

> FDA 483 for Auro Peptides Limited on August 21, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Auro Peptides Limited
- Inspection Date: 2026-08-21
- Product Type: drugs
- Office Name: Office of Partnerships
- Summary: Auro Peptides Limited in Kandi Mandal, India, an API manufacturer, was cited for significant facility and equipment deficiencies during an FDA inspection. Observations included uncleaned critical raw material storage, equipment discoloration, water damage in a recall room, and compromised flooring in a cold room storing API intermediates. These issues indicate poor control over manufacturing environments and potential product contamination risks.

## Related Officers

- [Investigator](https://www.keypedia.com/people/erik-w-koester/2bbab081-6783-40a1-83c1-b219bde22bd1)

Company: https://www.keypedia.com/companies/auro-peptides-limited/4b0dd862-e510-4737-9a98-522e70a98627

Office: https://www.keypedia.com/offices/office-of-partnerships/83acc701-fc5a-4876-bb34-7499e31541d3